Studies have shown genetic testing can improve survival rates in patients diagnosed with cancer by guiding decisions on prophylactic surgeries such as bilateral mastectomy and oophorectomy and enabling personalized treatment with targeted cancer therapies for BRCA1/2 mutation carriers [3]. This evidence concerns the gene BRCA1 and cancer.